Amerisource Health Services LLC is recalling 889 cartons of Voriconazole (50 mg) tablets, which were distributed by American Health Packaging. This prescription antifungal medication is being recalled due to manufacturing quality issues (cGMP deviations) that occurred when a supplier repackaged the product. The affected medication is packaged in cartons containing three blister cards, providing a total of 30 individual doses per carton.
Failure to follow current Good Manufacturing Practices (cGMP) during the repackaging process can compromise the quality and integrity of the medication. While no specific health incidents have been reported, using medication that does not meet manufacturing standards may pose a risk to patient safety.
You have 2 options:
Rx only medication distributed by American Health Packaging.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.